Human SARS-CoV-2 Nucleocapsid IgG (SARS-CoV-2 N IgG) ELISA Kit |
abx395203-100l |
Abbexa |
100 µl |
EUR 687.5 |
Human IgG antibody Laboratories manufactures the antibody responses to sars cov reagents distributed by Genprice. The Antibody Responses To Sars Cov reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Responses Group: To Sars
SARS-CoV-2 IgG ELISA Kit |
Biovision |
100 assays |
EUR 903.6 |
SARS-CoV-2 - Mpro ELISA IgG |
ImmunoStep |
1 |
EUR 572 |
Description: SARS-CoV-2 - Mpro ELISA IgG |
SARS-CoV-2 - Spike ELISA IgG |
ImmunoStep |
1 |
EUR 572 |
Description: SARS-CoV-2 - Spike ELISA IgG |
SARS-CoV-2 - RBD ELISA IgG |
ImmunoStep |
1 |
EUR 572 |
Description: SARS-CoV-2 - RBD ELISA IgG |
To Sars information
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
MBS8110617-01mL |
MyBiosource |
0.1mL |
EUR 480 |
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
MBS8110617-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2010 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
MBS8119476-002mL |
MyBiosource |
0.02mL |
EUR 210 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
MBS8119476-01mL |
MyBiosource |
0.1mL |
EUR 480 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
MBS8119476-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2010 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
MBS8119477-002mL |
MyBiosource |
0.02mL |
EUR 210 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
MBS8119477-01mL |
MyBiosource |
0.1mL |
EUR 480 |
SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb |
MBS8119477-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2010 |
SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb |
MBS8119480-002mL |
MyBiosource |
0.02mL |
EUR 210 |
SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb |
MBS8119480-01mL |
MyBiosource |
0.1mL |
EUR 480 |
SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb |
MBS8119480-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2010 |
SARS-CoV/SARS-CoV-2 Spike Antibody, Chimeric MAb |
MBS8574846-01mg |
MyBiosource |
0.1mg |
EUR 705 |
SARS-CoV/SARS-CoV-2 Spike Antibody, Chimeric MAb |
MBS8574846-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2910 |
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
MBS8574847-01mg |
MyBiosource |
0.1mg |
EUR 705 |
SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb |
MBS8574847-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2910 |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
9155-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
9155-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |